Excel · study · 2026
Vaccination with BCG reduces tau pathology and improve memory behaviors in the PS19 dementia mouse model
Listed in NCBI GEO
Retrospective studies among non-muscle invasive bladder cancer (NMIBC) patients have reported significant reductions (12–78%) in Alzheimer's disease (AD) incidence among BCG recipients versus controls.
Description
To understand the underlying mechanisms and discover novel therapeutic targets, we tested Mycobacterium bovis BCG Pasteur in a PS19 (P301S) mice model, which develop tauopathy-dependent neurodegeneration. We showed that BCG reduced hippocampal phospho‑tau, microgliosis, and astrocyte activation while preserving neuronal markers.
In vivo T2-MRI showed mitigated atrophy, with simultaneously increasing glutamate‑weighted CEST‑MRI readouts. Additionally, BCG improved survival and body weight, and amended cognitive physiology. Bulk-RNA sequencing of the hippocampus revealed- (1) restoration of the transcriptomics landscape of PS19 mice towards non-carrier controls after BCG-therapy, and interestingly (2) augmented antigen processing coupled with reduced neuroinflammation.
Read the rest (1 more)
Brain myeloid cell profiling by multicolor flow cytometry revealed decreased CD45hi-activated microglia subpopulation, without increasing total microglia, alongside elevated CD80 (Trained immunity marker) on peripheral myeloid cells. Functionally, primary brain myeloid cells displayed greater uptake of FITC‑tau fibrils and higher lactate production, indicating enhanced phagocytosis and glycolytic metabolism. Together, these findings indicate that (1) BCG-driven myeloid reprogramming limits neuroinflammation, enhances tau clearance, and rescues cognitive defects in a tauopathy model, and (2) BCG therapy merit consideration for human clinical trials against AD.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE326nnn/GSE326626 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE326626 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1446329 ncbi.nlm.nih.gov/bioproject/PRJNA1446329 ↗
project · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Mus musculus
- From keywords
- Life Sciences
- Inferred from text
- Cancer 75% · Disease 75% · Magnetic resonance imaging 65% · Sequencing 75%
Provenance · 1 source records, 11 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE326626 | 15 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[disease].local:disease:disease | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[modality].local:modality:mri | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[modality].local:modality:sequencing | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[organism].NCBITaxon:10090 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |